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Neurodegenerative diseases represent an increasing
burden in our aging society, yet the underlying meta-
bolic factors influencing onset and progression
remain poorly defined. The relationship between
impaired IGF-1/insulin-like signaling (IIS) and life-
span extension represents an opportunity to investi-
gate the interface ofmetabolismwith age-associated
neurodegeneration. Using data sets of established
DAF-2/IIS-signaling components in Caenorhabditis
elegans, we conducted systematic RNAi screens in
worms to select for daf-2-associated genetic modi-
fiers of a-synuclein misfolding and dopaminergic
neurodegeneration, two clinical hallmarks of Parkin-
son’s disease. An outcome of this strategy was the
identification of GPI-1/GPI, an enzyme in glucose
metabolism, as a daf-2-regulated modifier that acts
independent of the downstream cytoprotective tran-
scription factor DAF-16/FOXO to modulate neuro-
protection. Subsequent mechanistic analyses using
Drosophila and mouse primary neuron cultures
further validated the conserved nature of GPI neuro-
protection from a-synuclein proteotoxicity. Collec-
tively, these results support glucose metabolism as
a conserved functional node at the intersection of
proteostasis and neurodegeneration.
INTRODUCTION
Parkinson’s disease (PD) is an age-dependent neurodegenera-
tive disease characterized by the accumulation of a-synuclein(a-syn) within Lewy bodies and the selective loss of dopamine
(DA) neurons in the substantia nigra. While human genetic and
genomic studies have illuminated various contributors to disease
pathology, aging remains the single most definitive risk factor for
the development of PD (Amaducci and Tesco, 1994). Therefore,
an unresolved issue is the underlying molecular relationship be-
tween genetic factors influencing aging-associated metabolic
changes and the loss of DA neurons associated with PD.
The IGF-1/insulin-like signaling (IIS) pathway has been impli-
cated in human aging (Suh et al., 2008) and neurodegeneration
(Cohen and Dillin, 2008). This pathway has been studied exten-
sively in the nematode Caenorhabditis elegans (C. elegans),
where mutation of DAF-2, the sole worm insulin/IGF-1 receptor,
doubles lifespan and protects against a wide variety of cellular
stressors. This effect is mediated through activation of DAF-16,
the only FOXO/forkhead transcription factor (FOXO) in worms,
which regulates the expression of numerous cytoprotective
genes. In flies, reduced IIS viamutations in chico/insulin receptor
substrate (IRS) extend lifespan and provide stress resistance
(Clancy et al., 2001); phenotypes also are mediated by FOXO/
FKHR (Yamamoto and Tatar, 2011). Similarly, mutations in
Drosophila insulin-like receptor, the homolog of DAF-2, also
extend lifespan in adult flies (Tatar et al., 2001). While the IIS
pathway is comparably simplified in worms and flies, it is
important to note that this signaling cascade is nearly identical
to that in mammals (Taguchi and White, 2008). This provides
the exciting opportunity to utilize age-modified animals to enrich
for gene candidates involved in neurodegenerative disease
processes.
Among proteotoxicity models in worms, reduced IIS has
demonstrated protection against amyloid-b (Ab), polyglut-
amine-repeat (polyQ) proteins, and SOD-1 (Morley et al., 2002;
Cohen et al., 2006; Boccitto et al., 2012). Similarly, expression
of insulin-degrading enzyme inDrosophila suppresses Ab neuro-
toxicity (Tsuda et al., 2010). We previously established wormCell Metabolism 20, 145–157, July 1, 2014 ª2014 Elsevier Inc. 145
Figure 1. chico Mutation Protects against
Age-Dependent a-syn Toxicity in DA
Neurons
DA neurons in the brains of 20-day-old adult males
were visualized by expressing UAS-GFP tyrosine
hydroxylase (TH)-Gal4.
(A) DA neurons were counted in each of the
following DA subtype regions: anterior PAL (proto-
cerebral anterolateral); posterior protocerebral
posterior medial 1 (PPM1), PPM2, and PPM3; and
posterior PPL1 and PPL2 (protocerebral postero-
lateral). Values are averages of 15 brains per
genotype.
(B–E) Representative images of brains used for
neuron counts with insets of the PPL1 region.
(F and G) DA and DOPAC pools in 20-day-old male
heads. Values are averages of assays from three
independent head extractions and three technical
replicas for each extract, per genotype. Pools are
quantified as ng per fly head.
(H) Nitric oxide synthase activity in brains of 20-
day-old males was measured using a modified
Griess Reagent assay. Results are displayed as mM
concentration of nitrites in incubation medium.
Values are averages of three replications of 20 fly
brains per replication and three technical replicas
per genotype. Genotypes tested were as follows:
TH > GFP (UAS-GFP/+; TH-GAL4/+), chico (UAS-
GFP/chico; TH-GAL4/+), a-syn (UAS-GFP/+; TH-
GAL4/UAS-a-syn), and chico; a-syn (UAS-GFP/
chico; TH-GAL4/UAS-a-syn). All values compared
to TH > GFP controls unless otherwise indicated.
*p < 0.05; **p < 0.01; ***p < 0.001; one-way ANOVA
with a Dunnett’s post hoc test. Error bars
indicate ±SEM.
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induced DA neurodegeneration (Cao et al., 2005) and a-syn mis-
folding (Hamamichi et al., 2008), can be visualized and assayed.
Similarly, we have established a Drosophilamodel for DA neuro-
degeneration, which takes advantage of its greater neuronal
complexity to develop neurochemical and behavioral markers
of PD-related degeneration (Chaudhuri et al., 2007). Here, we
combine these established assay systems with the wealth of
existing data on aging in these distinct models as a synergistic
platform to uncover a relationship between metabolic change
and neurodegeneration.
In this study, we report that reduced IIS suppresses a-syn
toxicity and DA neurodegeneration inDrosophila andC. elegans.
We performed a large-scale RNAi screen in C. elegans to reveal
60 distinct genetic modifiers associated with this protection.
Subsequent bioinformatic and functional analyses of these
candidates identified GPI-1/GPI, a key enzyme in glucose meta-
bolism, as a potentmodifier of a-synmisfolding andDA neurode-
generation in C. elegans. We also found that mutation of Pgi/GPI
in Drosophila elevated a neuroinflammatory signal, disrupted DA
homeostasis, and induced DA neurodegeneration. Lastly, this
effect was translated to mammals, as Gpi1/GPI knockdown re-146 Cell Metabolism 20, 145–157, July 1, 2014 ª2014 Elsevier Inc.sulted in a-syn accumulation and neuro-
toxicity in mouse primary cortical neurons.
These data from worms, flies, and mice
collectively advance our understandingof proteotoxicity in the context of neurodegeneration, with
glucose metabolism as a conserved unifying feature.
RESULTS
Reduced IIS Suppresses a-Syn-Induced DA
Neurodegeneration in Drosophila
Although the IIS pathway is highly conserved in worms, flies,
and mammals, a direct link between the IIS pathway and
proteotoxicity or neurodegeneration has not previously been
demonstrated in Drosophila. Chico/IRS mutations extend
Drosophila lifespan and provide stress resistance (Clancy
et al., 2001). To determine whether reduced IIS modulates
a-syn toxicity in flies, we evaluated DA neurons in the CNS of
a-syn-expressing adults heterozygous for a mutant chico allele.
Quantification of these neuron clusters at day 1 (24–48 hr post-
eclosion) revealed no significant variations in the number of DA
neurons for any genotype (Figure S1A available online). At day
20, chico mutants maintain wild-type (WT) levels of DA neurons
in all clusters (Figures 1A–1C). In contrast, flies expressing
human a-syn showed significant declines in neuron numbers
in all DA neuron clusters. However, the presence of the chico
Figure 2. IIS Pathway Modulates a-Syn
Aggregation and a-Syn-Induced DA Neuro-
degeneration in C. elegans
(A–E) IIS pathway modulates a-syn-induced DA
neurodegeneration.
(A) IIS pathway modulates a-syn-induced DA neu-
rodegeneration at chronological aging (day 7) in
worms. daf-2 mutation dramatically suppressed
a-syn-induced DA neurodegeneration while the daf-
16 mutation enhanced a-syn-induced DA neuro-
degeneration. Notably, the daf-2; daf-16 double
mutation moderately suppressed a-syn-induced DA
neurodegeneration at chronological aging. White
bars indicate controls of the genetic backgrounds of
the normal (N2), daf-2, and daf-16 mutations.
(B) The daf-2 mutation did not suppress a-syn-
induced DA neurodegeneration at biological aging
(mean lifespan: day 20 for WT and day 40 for daf-2
mutants). Three independent trials were performed
(n = 90 total), and positives were considered signif-
icant if p < 0.05 via Student’s t test.
(C–E) Representative images of DA neurons in
Pdat-1::GFP (C), Pdat-1::GFP + Pdat-1::a-syn (D), and
Pdat-1::GFP + Pdat-1::a-syn + daf-2; dpy-1mutant (E).
Arrowheads denote normal neurons; arrows denote
degenerated neurons.
(F–L) IIS pathway modulates a-syn aggregation.
(F) In the WT background, a-syn::GFP accumulates
in the cytoplasm of muscle cells.
(G) In the daf-2mutant background, the a-syn::GFP
fusion protein is completely degraded. This daf-2
mutant + a-syn::GFP strain was used in an RNAi
screen.
(H and I) RNAi knockdown of daf-16 and hsp-16.11 resulted in a return of a-syn::GFP aggregates in the daf-2 background.
(J) Semiquantitative RT-PCR demonstrates that daf-2 mutation and RNAi do not affect mRNA level of a-syn::GFP.
(K) Western blot confirms the degradation of the fusion protein in the daf-2 mutant background.
(L) Summary of the 60 positive candidates that, when knocked down by RNAi in a daf-2 mutant + a-syn::GFP strain, reproducibly enhanced a-syn::GFP
accumulation. Positive candidates were categorized using KOG and/or GO annotations.
Error bars indicate ±SD.
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1A–1E).
IIS Mediates DA Homeostasis and Inflammatory
Signaling in Drosophila
To investigate the effect of chico on DA homeostasis, we quan-
tified cellular DA levels and turnover. At day 1, a-syn flies showed
no significant change in DA pools relative to the WT control (Fig-
ure S1B). Interestingly, chico mutant flies and chico mutant-
a-syn flies exhibited elevated levels of DA when compared to
either WT or a-syn flies alone (Figure S1B). By day 20, all geno-
types except a-syn have experienced a slight, age-dependent
reduction in DA (compare Figures 1F and S1B), while the a-syn
flies displayed strongly reduced DA, relative to controls. chico
mutation rescued the effect of a-syn on DA (Figure 1F).
We then quantified the ratio of DOPAC:DA, which we have
shown to be elevated in Drosophila DA neurons prior to degen-
eration (Chaudhuri et al., 2007). Analysis of 1-day-old flies re-
vealed no significant change in DA turnover in chico or chico;
a-syn versus the control, but elevated DA turnover was evident
in a-syn flies (Figure S1C). At 20 days posteclosion, control flies
had a slight increase in DA turnover associated with normal
aging, while chico mutants remained virtually unchanged (Fig-
ure 1G). Thus, flies expressing a-syn exhibit elevated DAturnover, which is partially rescued in the chico; a-syn strain
(Figure 1G).
We tested whether there was an accompanying inflammatory
response associated with these phenotypes. Using a modified
Griess reagent assay (Ajjuri and O’Donnell, 2013), we deter-
mined the levels of secreted nitrites, a stable metabolite of NO,
as a measure of relative inflammatory response. At day 1,
a-syn flies displayed an increase in NO levels, while chico and
chico; a-syn showed little variation from controls (Figure S1D).
A strong increase in NO levels was observed in a-syn flies after
20 days of aging, which was significantly reduced in chico;
a-syn transgenic flies (Figure 1H). Taken together, these findings
suggest theDrosophila IIS pathway can influence a-syn-induced
DA neurotoxicity.
IIS Pathway Modulates a-Syn-Induced DA
Neurodegeneration in C. elegans
Next, we investigated whether the link between the IIS pathway
and a-syn toxicity represents an evolutionarily conserved mech-
anism thatmay be applicable toward understanding PD.We per-
formed genetic crosses to generate daf-2 mutant worms that
overexpress human a-syn and GFP in DA neurons. At day 7,
we found that only 15% of a-syn worms displayed the WT
complement of six anterior DA neurons (Figures 2A and 2D)Cell Metabolism 20, 145–157, July 1, 2014 ª2014 Elsevier Inc. 147
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WT DA neurons (Figure 2C) (Hamamichi et al., 2008). Strikingly,
40% of daf-2; a-syn worms exhibited complete retention of DA
neurons (Figures 2A and 2E). A well-characterized downstream
component of the IIS pathway is DAF-16/FOXO, which functions
as a key regulator of numerous cytoprotective genes (Murphy
et al., 2003). We examined daf-16 mutants that overexpress
a-syn + GFP in DA neurons. As predicted, daf-16 mutation
enhanced neurodegeneration (Figure 2A). Surprisingly, we ob-
served an intermediate level of neuroprotection in daf-2; daf-16
double mutants overexpressing a-syn + GFP in DA neurons (Fig-
ure 2A). We verified that the genetic markers (unc-75 and dpy-1)
used in these mutants did not affect the DA neurodegeneration
phenotype by examining the balancers alone (Figure 2A) and
by crossing a-syn into the same daf-2 and daf-16 alleles
balanced with different genetic markers (Figure S2A). Our
findings that daf-2 mutation dramatically suppressed neurode-
generation, daf-16 mutants enhanced neurodegeneration, and
daf-2; daf-16 double mutants suppressed neurodegeneration
(although not to the same extent as daf-2 mutants) indicate
that DAF-16 is not the only genetic component responsible
for DA neuroprotection. Additional pathways downstream of
DAF-2 must contribute to neuroprotection.
DA Neurodegeneration at Biological versus
Chronological Aging in Worms
Associatedwith daf-2mutant lifespan extension is a delayed rate
of aging. We questioned whether daf-2-mediated neuroprotec-
tion at day 7 (chronological aging)might result from slower devel-
opment than WT (N2) control animals. We performed lifespan
assays to determine biological aging (mean lifespan) and found
that it was 20 days for WT;a-syn worms while it was 40 days
for daf-2; a-syn worms (data not shown). Interestingly, we found
that daf-2was no longer neuroprotective at biological aging (Fig-
ures 2B and S2B). These findings, together with our results
demonstrating IIS-mediated neuroprotection at chronological
aging in worms (Figures 2A and S2A) and flies (Figure 1), suggest
that the metabolic changes associated with reduced IIS are
responsible for protection against a-syn proteotoxicity and DA
neurodegeneration.
RNAi Screen for IIS-Mediated Protection against a-Syn
Misfolding
We next sought to identify the genetic factors responsible for this
IIS pathway-mediated protection against a-syn by generating a
daf-2 strain that overexpresses a-syn::GFP in muscle cells. Mis-
folded a-syn::GFP fusion protein accumulated in the cytoplasm
of N2worms (Figure 2F), while in daf-2mutants the fusion protein
was almost undetectable (Figure 2G). We reasoned that daf-2
mutation likely promoted degradation of the fusion protein rather
than affecting the a-syn::GFP expression level (Figures 2J and
2K). We then knocked down daf-16 and hsp-16.11 (positive con-
trols) via RNAi in daf-2; a-syn::GFP worms and discovered that
GFP inclusions reproducibly returned in these animals (Figures
2H and 2I).
To conduct the RNAi screen, we compiled a list of candidate
genes and/or proteins with clear human orthologs that are upre-
gulated in the daf-2 background (Murphy et al., 2003; McElwee
et al., 2004; Halaschek-Wiener et al., 2005; Dong et al., 2007)148 Cell Metabolism 20, 145–157, July 1, 2014 ª2014 Elsevier Inc.and genes that mediate daf-2 lifespan extension (Samuelson
et al., 2007). We included genes upregulated upon pan-neuronal
overexpression of a-syn (Vartiainen et al., 2006) and previously
identified genetic modifiers of a-syn misfolding and toxicity in
worms (Hamamichi et al., 2008; Kuwahara et al., 2008; van
Ham et al., 2008). In total, we assayed 625 targets in triplicate
and identified 60 genes that, when knocked down by RNAi,
reproducibly enhanced a-syn::GFP accumulation in the daf-2
mutant background (Tables S1 and S2; Figure 3A). These posi-
tive hits were categorized into functional groups using KOG
and GO annotations (Figure 2L; Table S2).
Examination of IIS-Mediated a-Syn Modifiers in
Additional Proteostasis Models
We next determined whether the 60 candidates were specific to
a-syn misfolding or are more general effectors of proteostasis. A
previous study identified genetic modifiers of polyQ aggregation
(Nollen et al., 2004), but none of those reported were identified in
the daf-2 background. We generated daf-2 worms that overex-
press Q82::GFP in muscle cells and, consistent with a previous
report (Morley et al., 2002), found that reduced IIS suppressed
polyQ aggregation (Figures 3B and 3C). We then performed
RNAi of the 60 candidates to identify genes that, when knocked
down in the daf-2 + Q82::GFP background, enhanced polyQ
aggregation (Figures 3A–3E). We discovered that 11/60 modi-
fiers of a-syn misfolding also affected polyQ aggregation (Fig-
ure 3F; Table S2).
We further investigated whether any of the 60 candidates
modified amyloid-beta (Ab) peptide toxicity. To evaluate these
targets, an established worm model that utilizes temperature-
sensitive induction of Ab-induced paralysis (Dostal and Link,
2010) was employed. We found that 8/60 targets enhanced
Ab-induced paralysis (Figures S3A and S3B; Table S2).
In total, we found that 18/60 a-syn effectors also modified
polyQ or Ab misfolding; one gene (Y45F10B.9, an uncharacter-
ized zinc-finger protein) impacted misfolding in all three models.
Thus, many of these genes appear to be general age-associated
modifiers of proteostasis that may affect susceptibility to a
variety of protein misfolding diseases.
The Majority of a-Syn Modifiers Act Independent of
DAF-16/FOXO
Since DAF-16 is a key regulator of numerous cytoprotective
genes and was found to mediate a-syn misfolding (Figure 2H)
and DA neurodegeneration (Figure 2A), we investigated whether
the 60 identified effectors were DAF-16 dependent. We per-
formed genetic crosses to generate daf-2; DAF-16::GFP worms
to visualize the distribution of DAF-16 within cells. Consistent
with previous reports (Lin et al., 2001), we observed predomi-
nantly nuclear localization of DAF-16 in untreated and empty
vector (EV) control RNAi-fed animals and increased cytoplasmic
distribution of DAF-16 in daf-18 RNAi-fed animals, in accor-
dance with daf-18 negative regulation of DAF-16 activity (Fig-
ure 3G–3I). We performed RNAi against each of the 60 targets
and examined the knockdown effect on DAF-16 localization.
Surprisingly, we found that only 11/60 candidates altered the
distribution of DAF-16 within worms, including 3/17 meta-
bolism-categorized candidates (Figures 3A and 3J; Table S2).
For example, a metabolic candidate, gpi-1, when knocked
Figure 3. Secondary Screening of Positive
Candidates
(A) Summary of secondary RNAi screens.
(B) In the WT background, Q82::GFP accumulates
in the cytoplasm of muscle cells.
(C) Q82::GFP aggregation is suppressed in daf-2
mutants, with approximately 9 ± 2 aggregates per
worm.
(D and E) RNAi knockdown of daf-16 or hsf-1 in
daf-2 mutant background caused a return of the
formation of Q82::GFP aggregates, with averages
of 18 ± 1 and 23 ± 6 aggregates per worm, on
average. We used the daf-2 + Q82::GFP worms
(C) to screen for modifiers of polyglutamine
aggregation.
(F) Summary of the candidates that, when
knocked down in daf-2 mutant background, sig-
nificantly enhanced polyQ aggregation. Two in-
dependent trials (n = 40 total) were performed, and
positives were determined as significant if *p <
0.05; one-way ANOVA with Dunnett post hoc test.
(G) In daf-2 mutants treated with EV control RNAi,
DAF-16::GFP is localized to the nucleus (arrow-
heads).
(H) In daf-2 mutants treated with daf-18 RNAi.
DAF-16::GFP is distributed evenly throughout the
cytoplasm.
(I) Graph showing quantification of DAF-16::GFP
localization in worms. Localization was scored
as ‘‘nuclear’’ (light gray), ‘‘cytoplasmic’’ (black), or
‘‘both’’ nuclear and cytoplasmic (dark gray). In
daf-2 mutants fed EV RNAi, DAF-16::GFP is pre-
dominantly localized to the nucleus. In daf-2
mutants exposed to the RNAi clone targeting daf-
18 there is increased cytoplasmic distribution of
DAF-16::GFP. We performed RNAi against all 60
positive candidates in daf-2; DAF-16::GFP worms
and examined the effect of candidate knockdown
on DAF-16 localization versus the DAF-16::GFP
pattern obtained with mock, or EV, RNAi knock-
down. One candidate from our screen, gpi-1
(RNAi), is displayed in this graph.
(J) Summary of candidates that, when knocked
down, altered DAF-16::GFP localization. Two in-
dependent trials (n = 40 total) were performed, and
positives were determined as significant if p < 0.05
via chi-square test.
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in the daf-2 background (Figure 3I; Table S2). Thus, while
some candidates may function as DAF-16-dependent effectors
of a-syn misfolding, the majority of these modifiers appear to
modulate proteotoxicity through distinct mechanisms.
In order to further define mechanistic pathways that may be
enriched in our screens, we analyzed our 60 a-syn modifiers
using IPA, which relies on the Ingenuity Pathway Knowledge
Base. Table S3 shows the five most significant functional net-
works of a-syn modifiers identified by IPA analysis. The leading
network included functional categories of energy production
and nucleic acid metabolism. We further investigated the mostCell Metabolism 20, 145significant functional network by visual-
izing its interaction with daf-2/IGFR and
daf-16/FOXO (Figure S4). We found that21 proteins from our initial 60 a-syn modifiers interact within
this network, revealing an important role for metabolism in
age-associated a-syn toxicity. We hypothesize this subset of
functional modifiers mediate metabolic changes connected
to PD.
Examination of IIS-Mediated a-Syn Modifiers in
C. elegans DA Neurons
Next we assessed whether our 60 candidate genes modify
a-syn-induced DA neurodegeneration independent of the daf-2
mutation. Our reasoning was 2-fold: (1) most candidates were
not daf-16 dependent, and (2) as described in Figure 2A, daf-2;–157, July 1, 2014 ª2014 Elsevier Inc. 149
Figure 4. IIS-Associated Modifiers of a-Syn Misfolding Also Affect a-Syn-Induced DA Neurodegeneration
(A) Graph showing percentage of 6-day-old worms with normal DA neurons for two RNAi targeting controls (EV and atg-7) and two positive candidates from
RNAi screen (gpi-1 and hrdl-1). RNAi targeting each of the 60 candidates was performed in sid-1 mutant worms overexpressing Punc-119::sid-1 + Pdat-1::GFP +
Pdat-1::a-syn.
(B–D) Representative images of Punc-119::SID-1 + Pdat-1::GFP + Pdat-1::a-syn worms treated with EV RNAi (B), hrdl-1 RNAi (C), and gpi-1 RNAi (D). Arrowheads
show intact DA neuron cell bodies. Arrows indicate areas where DA neurons have degenerated.
(E) Summary of candidates that, when knocked down, enhanced DA neurodegeneration in transgenic worms expressing Punc-119::sid-1 + Pdat-1::GFP +
Pdat-1::a-syn.
(F) Graph showing the percentage of 7-day-old worms with normal DA neurons for Pdat-1::GFP + Pdat-1::a-syn worms overexpressing either hrdl-1 or gpi-1.
(G–I) Representative images of Pdat-1::GFP + Pdat-1::a-syn worms (G), Pdat-1::GFP + Pdat-1::a-syn + Pdat-1::hrdl-1 worms (H), and Pdat-1::GFP + Pdat-1::a-syn +
Pdat-1::gpi-1 (I).*p < 0.05, one-way ANOVA with Dunnett post hoc test.
Error bars indicate ±SD.
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degeneration by 13%, compared to a 30% decrease in the WT
background, suggesting there are additional pathways impact-
ing neuroprotection in parallel to DAF-16. We utilized a worm
strain that enables DA neuron-selective RNAi with transgenic
animals expressing a-syn (and GFP) in DA neurons to knock
down the 60 IIS-related candidates (Harrington et al., 2012).
We found that 30/60 candidates upon RNAi treatment signifi-
cantly enhanced DA neurodegeneration (Figure 4A–4E; Table
S2). Interestingly, 10/30 positives were involved in the energy
production and metabolism IPA network (Figure S3), including
glucose-6-phosphate isomerase (gpi-1/GPI), a key enzyme in
glycolysis. Interestingly, when GPI-1 is secreted by cancer cells,
it can also serve as a cytokine to activate autocrine motility factor
(AMF) signaling (Haga et al., 2000). It was therefore significant
that the receptor for AMF (hrdl-1/AMFR) was also identified in
this screen. Accordingly, both gpi-1 and hrdl-1 RNAi enhanced
a-syn-induced DA neurotoxicity (Figures 2L and 4A–4D; Table
S2). Conversely, overexpression of gpi-1 and hrdl-1 in DA neu-
rons resulted in significant protection from a-syn-induced neuro-
toxicity (Figures 4F–4I).
GPI-1 Protects DA Neurons in Parallel to DAF-16
To investigate the mechanism for GPI-1-mediated neuroprotec-
tion, we performed combinatorial RNAi against daf-2 + gpi-1 and
daf-2 + hrdl-1 to determine whether daf-2-mediated neuropro-
tection is dependent on these gene products. Combinatorial
RNAi eliminated the neuroprotection phenotype conferred by
daf-2 RNAi (Figure 5A). Notably, neuroprotection decreased
79% in daf-2; gpi-1 double RNAi versus 30% in daf-2; daf-16
double mutants (Figures 5A versus 2A), suggesting the cellular
events involving gpi-1 provide greater protection than the DAF-
16 pathway. We also found that combinatorial RNAi against150 Cell Metabolism 20, 145–157, July 1, 2014 ª2014 Elsevier Inc.daf-16 + gpi-1 enhances DA neurodegeneration compared to
gpi-1 RNAi alone (Figure 5B), providing further evidence that
gpi-1 is functioning independently of daf-16. We validated this
result with quantitative RT-PCR and found that gpi-1 RNAi did
not significantly impact the expression level of two known
endogenous DAF-16 transcriptional targets, sod-3 and mtl-1
(Robida-Stubbs et al., 2012). Similar results were observed in
the WT genetic background (Figure 5C).
GPI-1 Influences Protein Homeostasis through
Glycolysis
We tested whether GPI-1 could regulate the folding of endoge-
nous metastable proteins by using worm strains carrying
temperature-sensitive (ts) mutations unc-15(e1402) and unc-
52(e669su250), encoding paramyosin and perlecan, respec-
tively. At permissive temperature, these ts metastable proteins
fold and function properly, while at elevated temperature the
proteins misfold and induce motility defects (Gidalevitz et al.,
2006). Figure 5D shows that gpi-1 RNAi at permissive tempera-
ture significantly (p < 0.01) reduced the motility of young adult
unc-15 and unc-52 worms by 46% and 37%, respectively, sug-
gesting a role for GPI-1 in maintaining global proteostasis.
To study the underlying mechanism impacting proteostasis,
we inquired whether GPI-1 neuroprotection involved glycolysis,
since this enzyme is involved in its initial steps. Treatment with
2-deoxyglucose (DOG), a glucose analog that blocks glycolysis,
enhanced a-syn-induced DA neurodegeneration in worms (Fig-
ure 5E) and a-syn-induced mobility defects in flies (Figure 5F).
Importantly, combinatorial treatment of worms with DOG +
gpi-1 RNAi did not enhance a-syn-induced DA neurodegenera-
tion compared to gpi-1 RNAi alone (Figure 5E). In addition,
excess glucose suppressed a-syn-induced mobility defects in
Drosophila (Figure 5F; Movies S1, S2, and S3). Lastly, we
Figure 5. GPI-1 Mechanistic Analyses
(A and B) Graphs depicting percentage of 6-day-old worms with normal neurons following combinatorial RNAi of daf-2 + EV control, gpi-1, or hrdl-1 (A) and
combinatorial RNAi of daf-16 + EV control or gpi-1 (B) in Punc-119::sid-1 + Pdat-1::GFP + Pdat-1::a-syn C. elegans. *p < 0.05; **p < 0.01, one-way ANOVA with
Dunnett post hoc test.
(C) No induction of endogenous DAF-16 target genes in response to gpi-1 RNAi. Quantitative RT-PCR was performed with young adult daf-2 mutant or N2 WT
worms expressing Punc-54::a-syn::GFP, treated with EV control RNAi, gpi-1 RNAi, or daf-16 RNAi (positive control). For each daf-16 target gene, its mRNA levels
were normalized to the expression in worms treated with EV control RNAi. Values are means ±SD (n = 3 independent biological samples with 100 worms in each).
P value was calculated by nonparametric one-way ANOVA. NS, not significant, compared with worms treated with EV control RNAi.
(D) gpi-1 RNAi at permissive temperature (16C throughout the experiment) significantly reduced the motility of young adult unc-15(e1402) and unc-
52(e669su250) worms. Animals were exposed to EV or gpi-1 RNAi from embryos. The movement of young adult worms were recorded and analyzed by
WormLab3.0 with the crawlingmode. Values aremeans ±SD (n = 3 independent experiments with 15–20worms in each). **p < 0.01, unpaired Student’s two tailed
t test with Welch correction.
(E) Graph showing percentage of 4-day-old worms with normal DA neurons. Punc-119::sid-1 + Pdat-1::GFP + Pdat-1::a-syn worms fed EV control RNAi or gpi-1RNAi
were treated with 0 mM, 5 mM, and 10 mM 2-DOG and then analyzed 24 hr after exposure. **p < 0.01, one-way ANOVA with Dunnett post hoc test. For (A)–(E),
error bars indicate ±SD.
(F) Mobility of a-syn expressing flies aged to 10 days and then fed 200 mMDOG or 1 M glucose for 5 days. *p < 0.05; **p < 0.01, one-way ANOVA with Bonferroni
post hoc test. Error bars indicate ±SEM.
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found these were unaffected (Figure S5), implying certain glyco-
lytic metabolites may be responsible neuroprotection. Along
with prior studies (Schulz et al., 2007; Tauffenberger et al.,
2012), these data provide strong evidence that GPI-1 mediates
proteotoxicity via glycolysis.
Pgi/GPI Mutation Induces DA Neurodegeneration in
Drosophila
We sought to investigate whether a relationship between
glucose metabolism, proteostasis, and neurodegeneration is
conserved in other species. To this end, we first examined the
link between IIS and the gpi-1 fly ortholog pgi. While heterozy-
gous chico mutants had no deficiency in climbing behavior,
heterozygous pgi mutants displayed a significant reduction in
mobility relative to WT flies (Figure 6A). The presence of themutant allele of chico in double heterozygotes was unable to
rescue the climbing deficits of heterozygous pgi mutants. This
result suggests that pgi acts downstream of chico or that the
two genes function in genetically separate pathways.
Next we examined whether pgi modulates a-syn-induced DA
neurodegeneration. A heterozygous pgi mutation was intro-
duced into flies expressing a-syn and GFP in DA neurons, under
the control of a TH-GAL4 driver. To investigate the effect of pgi
on a-syn toxicity, we compared DA neuron numbers for the
WT and heterozygous pgi mutant genotypes in GFP-expressing
neurons, in the absence and presence of a-syn. No significant
changes were observed DA neuron numbers for any genotype
at day 1 posteclosion (Figure S6A). However, we found a signif-
icant decline at day 20 in DA neuron numbers in pgi heterozy-
gous mutant brains in the absence of a-syn (Figures 6B–6D).
Similarly, a-syn, pgiWT flies exhibited significant degenerationCell Metabolism 20, 145–157, July 1, 2014 ª2014 Elsevier Inc. 151
Figure 6. Pgi/GPI Mutation Enhances a-Syn-Induced DA Neuron Loss
(A) Mobility assays of heterozygous chico and pgi mutant alleles, individually and in combination, relative to WT flies.
(B–D) DA neurons in the brains of 20-day-old adult males, visualized by TH-Gal4 driven GFP.
(B) Neurons were counted in anterior and posterior DA neuron clusters. Values are averages of 15 brains per genotype.
(C and D) Representative images of brains used for neuron counts with insets of the PPL1 region.
(E and F) DA and DOPAC pools weremeasured in heads of 20-day-old male flies. Assay values were determined using three independent head extracts and three
technical replicas for each genotype and calculated as ng per fly head.
(G) Nitric oxide synthase activity in brains of 20-day-old males was measured using a modified Griess Reagent assay. Results are displayed as mMconcentration
of nitrites in incubation medium. Values are averages of three replications of 20 fly brains per replication and three technical replicas per genotype. Genotypes for
strains tested are as follows: TH > GFP (UAS-GFP/+; TH-GAL4/+), Pgi (UAS-GFP/Pgi; TH-GAL4/+), a-syn (UAS-GFP/+; TH-GAL4/UAS-a-syn), and Pgi; a-syn
(UAS-GFP/Pgi; TH-GAL4/UAS-a-syn). These assays were performed simultaneously with those in Figure 1 and employed the same TH>GFP controls. *p < 0.05;
**p < 0.01; ***p < 0.001; one-way ANOVA followed by Dunnett’s post hoc test analysis. Error bars indicate ±SEM.
(H) Western blot reveals that levels of the apoptosis factor death caspase-1 (DCP-1) in 20-day-old adult male heads was elevated 1.6-fold in the pgimutant flies
and reduced slightly in chico alone (0.83:1). Expression of chico and pgi together only slightly ameliorated DCP-1 protein expression relative to WT (1.23: 1).
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allele with a-syn significantly reduced neuron numbers further
in nearly all DA neuron clusters (Figures 6B–6D).
Pgi/GPI Mutation Exacerbates the Effects of a-Syn on
DA Metabolism and Nitric Oxide Production in
Drosophila
Since glucose restriction increases oxidative stress in worms
(Schulz et al., 2007), we investigated whether the pgi mutation
would result in cytosolic accumulation and oxidation of DA
in fly brains. HPLC analysis of DA and DOPAC levels in fly
heads revealed that even at day 1 posteclosion pgi mutant flies
possessed significantly lower DA levels (Figure S6B) and
dramatically elevated DOPAC:DA ratios (Figure S6C). While
a-syn alone did not result in significant diminution of DA pools
or elevated DA turnover at day 1, it enhanced the effects of the
pgi mutant allele on both DA loss and DOPAC production (Fig-152 Cell Metabolism 20, 145–157, July 1, 2014 ª2014 Elsevier Inc.ures S6B and S6C). After aging to 20 days, DA turnover in pgi
mutants increased nearly 2.5-fold (Figure 6F). At this age,
a-syn flies displayed significantly reduced DA, further loss in
combination with the pgimutation, and an enhanced DOPAC:DA
ratio (Figures 6E and 6F). These findings reveal a strong age-
associated effect of pgi on DA regulation.
We assayedNOproduction in heterozygous pgimutants alone
and in the a-syn background. Both pgi mutants and a-syn-
expressing flies individually displayed strong inflammatory re-
sponses as measured by NO production, and in combination,
nearly a 4-fold increase in NO relative to control flies was
observed at day 1 and day 20 posteclosion (Figures S6D and
6G). Consistent with these data, levels of the apoptosis factor
DCP-1, encoded by death caspase-1, were significantly elevated
in pgimutant flies (Figure 6H). While chico alone showed a minor
decrease in DCP-1 levels, compared to WT flies, expressing
both chico and pgi together only slightly ameliorated DCP-1
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summary, a-syn expression and pgi mutation individually cause
deleterious effects on DA neurons, and the combination of these
two modifications is synergistic in their damage to the adult
Drosophila brain.
Knockdown of Gpi1/GPI in Mouse Primary Cortical
Neurons
To determine if the effect of gpi-1/pgi knockdown translated to
a mammalian system, mouse neuronal cortical cultures were
transduced with lentiviral constructs expressing a short hairpin
RNA (shRNA) sequence targeted against mouse Gpi1. Infection
of neurons at a multiplicity of infection (MOI) of 1 resulted in over
90% knockdown of GPI1 protein, compared to cells infected
with a scrambled shRNA sequence (scrb), when assessed at
7 days postinfection (dpi) (Figure 7A). Neurotoxicity was deter-
mined by immunofluorescence analysis of neurofilament protein,
a sensitive assay that measures the degeneration of neurites.
Infection with lenti-Gpi1-shRNA at MOI 0.5 resulted in significant
neurotoxicity compared to both non-transduced (N.T.) and scrb-
infected neurons, when assessed at both 7 and 9 dpi (Figure 7B).
Increasing the viral titer to an MOI of 1 further enhanced the
neurotoxic effect (Figure 7C).
We subsequently characterized the effect of Gpi1 knockdown
on a-syn solubility in neuronal cultures by sequential biochem-
ical extraction. Neurons from Gpi1-shRNA-transduced neurons
were sequentially extracted in 1% Triton X-100, 2% SDS, then
70% formic acid (FA), and compared to extracts from scrb-
shRNA-infected neurons. Western blot analysis revealed that
Gpi1 knockdown significantly reduced the levels of Triton
X-100-soluble monomeric a-syn migrating at 18 kDa by 50%,
while increasing the levels of soluble high molecular weight
(HMW) oligomers by 3-fold (Figures 7D–7H). Additionally, Gpi1
knockdown appeared to cause a dramatic accumulation of
Triton X-100 insoluble a-syn (5 fold increase) extracted in
SDS and FA-containing fractions (Figures 7D–7F and 7I). The
solubility changes of a-syn were confirmed with two antibodies
that were generated against unmodified a-syn (syn 202 and
SNL-1), as well mAb syn 505, which was generated against
oxidized/nitrated a-syn (Duda et al., 2002) and recognizes cross-
linked species of the protein; thus, syn 505 preferentially detects
misfolded forms of a-syn (Waxman et al., 2008). These results
indicate that GPI1 depletion results in neurotoxicity and
concomitantly causes the accumulation of soluble a-syn oligo-
mers and insoluble species.
DISCUSSION
The wealth of information that has accumulated from decades of
elegant research in model systems has led to lists of genetic fac-
tors influencing lifespan and healthspan (Kenyon, 2010; Gems
and Partridge, 2013). Likewise, human genetic studies have
also generated an expanding catalog of heritable and candidate
susceptibility factors for PD. We set out to better define the mo-
lecular intersection of aging and PD in the context of established
genetic modifiers by taking advantage of preexisting data sets
and the respective strengths of select model systems. Without
question, the IIS pathway is central to understanding the organ-
ismal control of metabolism.We show here that reduced IIS sup-presses a-syn misfolding and neurotoxicity in flies and worms.
Morever, we identify a conserved DAF-16/FOXO-independent
mechanism through which the IIS pathway integrates metabolic
regulation with proteotoxicity and DA neurodegeneration.
GPI-1 is upregulated in daf-2 mutants (Dong et al., 2007) and
functions independently of DAF-16/FOXO to modulate neurode-
generation (Figure 4). Interestingly, GPI-1 RNAi/mutation ex-
tends lifespan in C. elegans (Schulz et al., 2007) and influences
lifespan in Drosophila (Lai et al., 2007). While this relationship is
seemingly paradoxical, it highlights the distinction between
chronological aging and neuronal dysfunction and health. An
expression level change in GPI-1 in daf-2 mutant worms does
not necessarily contribute to the further lifespan extension and
may reflect a compensatorymechanism activated by a reduction
in DAF-2 signaling. Indeed, this was implied by our result that
gpi-1 + daf-2 combinatorial RNAi abolished the protective effect
of daf-2 RNAi (Figure 5A) and was echoed by the climbing assay
in flies (Figure 6A). We also determined that GPI RNAi/mutation
enhances DA metabolism (Figures 6F and S6C); induces an in-
flammatory response and apoptosis (Figure 6G, 6H, and S6D);
and causes widespread protein aggregation and neurodegener-
ation in worms, flies, and mammalian primary neurons (Figures
4–7; Table S2), but it does not affect ATP production (Figure S5).
Furthermore, we found that increased glucose metabolism via
overexpression of GPI and glucose surplus suppressed a-syn-
induced DA neurodegeneration in worms (Figure 4F) and flies
(Figure 5F), respectively. Our data, together with Tauffenberger
et al. (2012), support a role for GPI in mediating proteotoxicity
and neurodegeneration via glucose metabolism.
In addition to its role as a cytoplasmic enzyme, GPI has an
alternative role in cancer cells, where it acts as a ligand (GPI-1/
AMF) in the AMF pathway. Its receptor, HRDL-1/AMFR, was
also identified in our screen to modify a-syn misfolding and neu-
rodegeneration (Figure 4). AMF/AMFR attenuate ER stress and
apoptosis in cancer cells (Fu et al., 2011). However, HRDL-1
also functions as a homolog of HRD family of E3 ligases that
regulate HMG-CoA reductase degradation. The identification
of HRDL-1/AMRF activity in neuroprotection suggests a poten-
tial relationship between cholesterol biosynthesis and a-syn
toxicity in PD. This is underscored by the results of Scherzer
et al. (2003), in which changes in the expression of lipid meta-
bolism genes represented a major response to a-syn expression
in Drosophila. Albeit (presumably) mechanistically distinct, these
data are intriguing given the reported efficacy of statins in PD
models (Bar-On et al., 2008). How an alteration of lipid meta-
bolism contributes to a-synmisfolding and neurotoxicity remains
to be determined. Nevertheless, glucose metabolism may
impact a-syn toxicity through a mechanism involving the eleva-
tion of certain lipids that bind to a-syn and facilitate the process
of toxic oligomerization.
Importantly, threepositive candidates from this studyareasso-
ciated with neurodegenerative disease in patients: C01A2.4/
CHMP2B (frontotemporal dementia and degeneration; Isaacs
et al., 2011), gpd-2/GAPDH (Parkinson’s, Alzheimer’s, and Hun-
tington’s ; Mazzola and Sirover, 2001), and C54D10.10/TFPI
(Alzheimer’s; Piazza et al., 2012). Notably, we did not identify
C. elegans orthologs of other known heritable PD genes among
these modifiers. While this may seem surprising, in the context
of reduced IIS, these findings were not completely unexpected.Cell Metabolism 20, 145–157, July 1, 2014 ª2014 Elsevier Inc. 153
Figure 7. Knockdown of Gpi1/GPI in Mouse Cortical Neurons Causes Neurotoxicity and a-Syn Accumulation
(A) Neurons were transduced with lenti-Gpi1 shRNA or scrambled shRNA (scrb) at MOI 1 and harvested at 7 dpi. GPI1 protein levels were determined by western
blot and densitometry. a-tubulin was used as a loading control (n = 4).
(B) Neurotoxicity was assessed by neurofilament measurement at dpi 7 and 9 in neurons infected at MOI 0.5.
(C) Neurotoxicity assessment at MOI 1 infection. (n = 4.)
(D–F) Sequential extraction analysis of dpi 7 neurons infected at MOI 0.5 using anti-a-syn antibodies syn 202, SNL-1, and syn 505. Reactivity with syn 505 reveals
the presence of misfolded, oxidized/nitrated a-syn. Neural specific enolase (NSE) was used as a loading control.
(G–I) Densitometric quantification of various biochemical forms of a-syn (n = 2 for syn 202, n = 2 for SNL-1, and n = 1 for syn 505). Values are the mean
SEM; *p < 0.05.
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disease until later in life, demonstrating a key role for the meta-
bolic changes associatedwith aging in disease onset. Consistent
with this point is the observation that energy-metabolism-associ-
atedgenesare a key classof geneswhoseexpression ismodified
as a-syn-induced neurodegeneration progresses (Scherzer
et al., 2003). Likewise, our screening paradigm involved analysis154 Cell Metabolism 20, 145–157, July 1, 2014 ª2014 Elsevier Inc.of different phenotypes (aggregation; degeneration) in distinct
cell types (bodywall muscles; dopamine neurons). Thus, contex-
tual differences in expression may account for an absence of
select modifiers. These collective results highlight the utility of
model systems in deciphering the integrated consequences
of imbalances in protein management and metabolic networks
on neuronal survival.
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Basic C. elegans Genetic and Biochemical Methods
Strain maintenance, genetic crosses, creation of transgenic nematodes, and
supporting biochemical procedures were carried out using standard methods
(see Supplemental Experimental Procedures for details).
C. elegans RNAi Screening
Screening was performed using RNAi feeding clones (Geneservice, Cam-
bridge). Twenty age-synchronized young adult F1 animals were analyzed
per clone. The RNAi clones resulting in significant a-syn aggregation (80%
of worms with increased quantity and size of aggregates) were scored as
positive, and all positives were tested in triplicate. RNAi feeding procedures,
assays, and worm strains are described in the Supplemental Experimental
Procedures.
C. elegans Secondary Screening of Candidate Genes from RNAi
Screen
Nematode models of polyglutamine aggregation in bodywall muscle cells, Ab
paralysis, DAF-16::GFP localization, and a-syn-induced DA neurodegenera-
tion were examined as secondary screening assays. These models were
interrogated using RNAi of the 60 gene candidates identified from the screen
by exploring by the impact of gene knockdown on F1 offspring (versus EV
RNAi). Polyglutamine aggregation and Ab paralysis worm models (daf-2;
Punc-54::Q82::GFP and Pmyo-3::Ab1-42) were scored at the L3-stage for total
number of aggregates or numbers of worms paralyzed, respectively. DA neu-
rons were also examined for a-syn-induced neurodegeneration in 7-day-old
animals (sid-1; Punc-119::sid-1; Pdat-1::a-syn; Pdat-1::GFP) that had been
exposed to RNAi since embryonic stages. A worm was considered rescued
when all six anterior DA neurons were intact had no visible signs of degener-
ation. Statistical analyses for RNAi experiments with Q82 aggregation, Ab
paralysis, and DA neuron degeneration were performed using the one-way
ANOVA with Dunnett’s post hoc test (p < 0.05) to compare control worms
(fed RNAi bacteria not targeting any gene) with experimental worms (fed
RNAi bacteria targeting candidate gene). C. elegans scored for DAF-
16::GFP localization were L3 staged and had been exposed to RNAi since
the embryonic stage (daf-2; Pdaf-16a/b::GFP). For each worm, GFP localization
was scored as ‘‘completely nuclear,’’ ‘‘both nuclear and cytoplasmic,’’ or
‘‘completely cytoplasmic.’’ Two independent trials (n = 40 total) were per-
formed, and positives were determined as significant if p < 0.05, via a chi-
square test. Supplemental Experimental Procedures provide more details
for all of these procedures.
C. elegans ts Mutant Phenotype Assays
The nematode mutants, unc-15 and unc-52, were treated with EV or gpi-1
RNAi and maintained at permissive temperature. Behavioral analysis was re-
corded and analyzed using WormLab3.0 (MBF Bioscience) with Kalman
smoothing. Three independent trials were conducted, eachwith 15–20worms.
An unpaired Student’s two-tailed t test with Welch correction was used to
determine statistical significance (see Supplemental Experimental Procedures
for details).
DOG Analysis in C. elegans
DA neurodegeneration assays were performed on Pdat-1::a-syn, Pdat-1::GFP
animals that were age-synchronized, exposed to 5 or 10 mM DOG for 24 hr,
and analyzed at day 4. Three trials were performed (n = 90 animals/treatment);
one-way ANOVA with Dunnett post hoc test.
Ingenuity Pathway Analysis
The Ingenuity Pathway Analysis (IPA) software (Ingenuity Systems; http://
www.ingenuity.com) was used for distributing the 60 positive candidate genes
from our primary screen into biological networks and for evaluation of func-
tional significance.
Basic Drosophila Genetic and Biochemical Methods
Strain maintenance, genetic crosses, and supporting biochemical procedures
were carried out using standard methods (see Supplemental Experimental
Procedures for details).Drosophila DA Neuron Quantification
DA neurons from adult males were dissected for analysis either 1 or 20 days
posteclosion. These neurons were visualized by expression of GFP under
the control of the DA neuron driver TH-Gal4, and samples were quantified
following confocal microscopy imaging. Additional details are outlined in the
Supplemental Experimental Procedures section.
Drosophila DA Neuron HPLC and NO Synthase Analyses
Monoamines from male heads were separated using HPLC as described in
Chaudhuri et al. (2007). A modified Griess reagent assay described in Ajjuri
and O’Donnell (2013) was used to quantify nitric oxide synthase activity.
Male heads were also examined in this assay. For all experiments, genotypes
were analyzed in triplicate and statistics were analyzed using one-way ANOVA
followed by Dunnett post hoc test. See Supplemental Experimental Proce-
dures for more details.
Drosophila DOG and Glucose Feeding
Male flies were aged to 10 days posteclosion and then fed either standard
corn syrup food or standard food supplemented with either 200 mM
2-DOG or glucose with a final concentration of 1 M continuously for
5 days. Statistics were analyzed using one-way ANOVA followed by Bonfer-
roni post hoc test.
Drosophila Climbing Assay
Flies were anesthetized using cold coma, transferred in groups of ten to climb-
ing vials, and allowed 45 min to recuperate. Vials were gently tapped before
each trial, and climbing was scored by calculating the number of flies to climb
6 cm in 20 s. The results represent ten trials with three repetitions per trial.
Statistical analyses were performed using one-way ANOVA with Bonferroni
post hoc test.
Mouse Cortical Cultures, Lentiviral Infection, and Neurotoxicity
Analysis
Murine neuronal cortical cells were obtained at embryonic day 17, as previ-
ously described (Tsika et al., 2010). Cells were seeded in 96-well plates at
50,000 cells/well and infected at 5 days in vitro (DIV) with lentiviral particles
containing shRNA againstGpi1 at either MOI 0.5 or 1. The cells were then fixed
in 4%paraformaldehyde at the indicated time points. The staining and analysis
procedures have been described in detail previously (Tsika et al., 2010).
Neurotoxicity analysis was performed with two separate culture preparations,
with four replicates for each preparation. One-way ANOVA with Tukey’s
post hoc test was used to determine statistical significance, and p < 0.05
was considered significant. See Supplemental Experimental Procedures for
details.
Sequential Biochemical Extraction of Mouse Neuronal Cultures
6,000,000 cells/condition were extracted for SDS-PAGE analyses using the
methods described in the Supplemental Experimental Procedures section.
The subsequent gels were transferred to polyvinylidene difluoride membranes
and probed with anti-a-syn antibodies (syn 202, dilution 1:500, Covance;
SNL-1, dilution 1:500, gift of Benoit I. Giasson, University of Pennsylvania; or
syn 505, dilution 1:500, Invitrogen). Anti-Neural-specific enolase and anti-
alpha-tubulin were used as loading controls. Primary antibodies were de-
tected with anti-mouse or rabbit IgG conjugated to IRDye 680 or 800. For
controls, blots were scanned after the blocking step to determine autofluores-
cent bands and also after the addition of secondary Ab alone. Any nonspecific
bands detected were not included in densitometric analyses. Quantification of
the Triton-soluble band migrating at 18 kDa was used for monomer measure-
ments (syn 202 and SNL-1); quantification of aggregated forms of a-syn was
done with syn 202, SNL-1, and syn 505 and repeated with separated culture
preparations. A Student’s t test was used to determine statistical significance;
p < 0.05 was considered significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures, three tables, three movies, and
Supplemental Experimental Procedures and can be found with this article
online at http://dx.doi.org/10.1016/j.cmet.2014.04.017.Cell Metabolism 20, 145–157, July 1, 2014 ª2014 Elsevier Inc. 155
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